Gastroparesis Market to Reach $6,025.11 Billion, Globally, by 2027 at 4.3% CAGR: The Insight Partners

Gastroparesis Market Forecast to 2027 - COVID-19 Impact and Analysis - by Type, Drug Class Type, and Distribution Channel," the market is expected to reach US$ 6,025.11 million by 2027 from US$ 4,338.61 million in 2019; it is estimated to grow at a CAGR of 4.3% from 2020 to 2027. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The market growth is primarily attributed to the increasing diabetes prevalence and growing geriatric population. However, side-effects of gastroparesis drugs restrain the growth of the market.

Download Sample PDF Brochure of this research study at - https://www.theinsightpartners.com/sample/TIPRE00008992?utm_source=OpenPR&utm_medium=10823

On the basis of type, the gastroparesis market is segmented into idiopathic, diabetic, post-surgical, and others. The idiopathic type held the largest share of the market in 2019; however, the market for the diabetic type is estimated to grow at the highest CAGR during the forecast period. The rising number of research and development activities pertaining to the management of diabetic gastroparesis is estimated to offer lucrative opportunities for the growth of the market for the diabetic segment.

The global Gastroparesis Market is segmented based on. The segmentation in this research study has been finalized post in-depth secondary research and extensive primary research. In addition, the market is also segmented on the basis of technology offered by the leading participants in the industry in order to understand widely used market specific terminologies. Thus, we have incorporated the segments of the research and have finalized the market segmentation.

The COVID-19 pandemic has disrupted supply chain of over-the-counter (OTC) and prescription drugs, and this is likely to limit the market growth in the next few quarters. Moreover, the emphasis of health care providers and medical industries on COVID-19 has led to the lowered focus on the diagnosis and treatment for gastroparesis, which is limiting the market growth to a certain extent.

Some of the key players in this market include Company: EVOKE PHARMA, Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.), Johnson And Johnson Services, Inc., Allergan Plc, NEUROGASTRX, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD, Pfizer Inc., ANI Pharmaceuticals, Inc., Ipca Laboratories Ltd., and Cinrx Pharma, LLC (Cindome Pharma) are among the leading companies operating in the gastroparesis market.

Gastroparesis Market Research Report Scenario includes:
The report provides qualitative and quantitative trends of global Gastroparesis Market across type, type of products, service, and geography.
The report starts with the key takeaways (Chapter Two), highlighting the key trends and outlook of the global Gastroparesis Market.
Chapter Three provides the research methodology of the study.
Chapter Four further provides PEST analysis for each region.
Chapter Five highlights the key industry dynamics in the Gastroparesis Market, including factors that are driving the market, prevailing deterrent, potential opportunities as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
Chapter Six discusses the global Gastroparesis Market scenario, in terms of historical market revenues, and forecast till the year 2027.
The report also covers a detailed chapter of the analysis on COVID-19 impact on this market at global and regional level in our final reports.

Order a Copy of this Research Study at -
https://www.theinsightpartners.com/buy/TIPRE00008992?utm_source=OpenPR&utm_medium=10823

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.